Clinuvel Pharmaceuticals Limited (ASX:CUV)
11.68
-0.07 (-0.60%)
Mar 28, 2025, 4:10 PM AEST
Clinuvel Pharmaceuticals Revenue
Clinuvel Pharmaceuticals had revenue of 35.65M AUD in the half year ending December 31, 2024, with 21.39% growth. This brings the company's revenue in the last twelve months to 91.02M, up 11.34% year-over-year. In the fiscal year ending June 30, 2024, Clinuvel Pharmaceuticals had annual revenue of 88.18M with 12.59% growth.
Revenue (ttm)
91.02M
Revenue Growth
+11.34%
P/S Ratio
6.43
Revenue / Employee
5.69M
Employees
16
Market Cap
583.38M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 88.18M | 9.86M | 12.59% |
Jun 30, 2023 | 78.32M | 12.60M | 19.17% |
Jun 30, 2022 | 65.72M | 17.40M | 36.02% |
Jun 30, 2021 | 48.32M | 15.75M | 48.37% |
Jun 30, 2020 | 32.57M | 1.52M | 4.89% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |
Clinuvel Pharmaceuticals News
- 16 days ago - Half Year 2025 Clinuvel Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 25 days ago - Clinuvel Introduces Groundbreaking Vitiligo Program at the World's Biggest Dermatology Meeting, AAD 2025 - GlobeNewsWire
- 4 weeks ago - Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Lady Gaga portends ASX pay blushes - The Australian Financial Review
- 6 months ago - CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP - GlobeNewsWire
- 7 months ago - Clinuvel Pharmaceuticals Limited (CLVLY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Clinuvel Pharmaceuticals Limited 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 months ago - Clinuvel Pharmaceuticals GAAP EPS of A$0.72, revenue of A$96.3M - Seeking Alpha